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Abstract
The efficacy of mechanical circulatory support in acute myocardial infarction is dependent upon the size of the infarct. If
applied early, mechanical support to reduce reperfusion injury appears to be effective in reducing infarct size in animal studies.
The optimal timing of reperfusion is uncertain and requires further investigation. Efficient unloading appears to be essential in
increasing the efficacy of the type of mechanical support and may favor one over another.
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Background
When considering the management of shock, the topic of
reperfusion injury in acute myocardial infarction (AMI) is
challenging. Management must balance preventative
cardiology and critical care, as the initial problem lies with the
infarction rather than the shock.
There is a clear relationship between the size of an infarct
and the prognosis after myocardial infarction. Data from ten
randomized clinical trials where magnetic resonance imaging
was done after an infarction show a clear correlation between
all-cause mortality and heart failure hospitalization with the
size of the infarction.1 Importantly, in patients where the final
size was 8% or less of area at risk, there was little to no
mortality and very little morbidity.
The management solution for patients with AMI shock is
to re-perfuse early in the treatment process. However, even if

the patient presentation, treatment plan, and procedure are the
same, patients can have very different hearts after reperfusion,
and this is a consequence of reperfusion injury.
The pathophysiology behind reperfusion injuries is
complex, but there is an understanding that cardiomyocyte
death due to necrosis and apoptosis is important in the process.
Changes in microcirculation, such as microvascular stasis and
hemorrhage, tissue edema, and capillary compression, are also
important. Clearly, strategies to address these mechanisms and
minimize reperfusion injury would have a great impact on
outcomes in AMI and, in turn, the development and prognosis
of cardiogenic shock in this setting. There have been several
studies that aimed to reduce reperfusion injury utilizing
pharmacological strategies and remote ischemia by the use of
blood pressure cuffs in ambulances en route to the hospital.
Thus far, the results have been inconsistent.2
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Use of Mechanical Circulatory Support
These inconsistencies led to the proposal that mechanical
circulatory support (MCS) might be an efficient way to reduce
reperfusion injury. In the setting of an AMI, MCS increases
collateral coronary perfusion pressure and decreases left
ventricular pressure, diastolic pressure, wall stress, and,
consequently, myocardial oxygen consumption. The efficacy
is dependent on the size of the infarct. Because of this, the
question becomes: can MCS in AMI shock reduce reperfusion
injury and infarct size? If so, how does it do it? How should
reperfusion be timed with respect to the onset of unloading?

Animal Studies
MCS and infarct size were investigated in a study on
sheep with left anterior coronary artery (LAD) occlusion.3 The
control group had reperfusion after 60 minutes of ischemia,
while the group treated with an Impella CP (Abiomed) had
immediate reperfusion. The group with full support from the
onset had a lower myocardial oxygen extraction than the
control group; however, both groups showed decreased infarct
size.3
Another study in a pig model investigated MSC efficacy
after 90 minutes of LAD occlusion with a balloon. 4 Four
groups were evaluated: a reperfusion-only group (Group 1), a
group that received an Impella CP device for 15 minutes
before reperfusion (Group 2), a group that had an Impella CP
on for 30 minutes before reperfusion (Group 3), and a group
that had immediate reperfusion followed by circulatory
support (Group 4). Group 3 had the smallest infarction. 4
This same study also investigated different molecules
related to the reperfusion process.4 Specifically, stromal cellderived factor 1-alpha (SDF1-alpha) was reduced in the group
that did not receive MCS (Group 1). The group treated with
unloading before reperfusion (Group 2) had a more normal
level of SDF1-alpha. In addition, scar tissue formation was
negatively associated with plasma SDF1-alpha, indicating that
the molecule might be secreted by the heart to reduce
reperfusion injury. This was further investigated in a model
where SDF1-alpha was blocked, showing an attenuated effect
of reperfusion.4 The results challenge the understanding that
“time is muscle,” as a strong indication that delaying
reperfusion by 30 minutes with circulatory unloading onboard
was associated with improved outcomes.
A similar study using a pig model contested these results.5
The effects of 60 minutes of ischemia and MCS were
investigated in 3 groups: Group 1 with conventional ischemia
with reperfusion, Group 2 with upfront unloading with an
Impella for 30 minutes before reperfusion, and Group 3 where
unloading and reperfusion were done simultaneously after 60
minutes of ischemia. Group 3 had the smallest infarct size, but
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no difference existed between Groups 1 and 2. 5 While there
may be differences between these studies, the most important
being the duration of ischemia, there is still a need for further
understanding.
In a meta-analysis of several animal studies investigating
the effects of MCS and unloading in AMI, there appears to be
a 2.2% absolute reduction in infarct size, which corresponds
to a relative reduction of ~10%.6
With the understanding that MCS works in the setting of
AMI, the next step is to investigate which type of support
works best. A study involving LAD occlusion for 120 minutes
in pigs explored MCS type and efficacy in reducing infarct
size in 3 groups.7 Group 1 had continued occlusion with
Impella support, Group 2 had re-perfusion, and Group 3 had
veno-arterial extracorporeal membrane oxygenation (V-A
ECMO) re-perfusion. Group 3 was associated with the largest
infarct size, while Group 1 showed a decreased infarct size.
Group 1 also showed a reduction in left ventricular (LV)
stroke work, while Group 3 showed no change. 7 The study
also examined collateral coronary perfusion by measuring the
coronary collateral flow index and focusing on wedge
pressure. Wedge pressure was positively influenced by
unloading with an Impella.7 No change was noticed with V-A
ECMO, suggesting that collateral perfusion is essential and
may improve the microvascular environment, leading to
smaller infarcts.
It is essential to acknowledge the limitations of using
animal models. These studies use 100% controlled occlusion
with no disease of other vessels, and the time of occlusion is
known. In contrast, patients often have partial reflow due to
heparin administration, and occlusion time is rarely known for
certain. In addition, reocclussion or distal embolization are
always risks. Concomitant coronary disease must be
considered as it can limit collateral flow and induce
preconditioning that can potentially be beneficial for
reperfusion injury. Arrhythmias can also play a significant
role in these patients.

Clinical Studies
There is limited clinical data available exploring AMI
shock and MCS efficacy. The CRISP AMI randomized trial
compared percutaneous coronary intervention (PCI) alone to
PCI with an intra-aortic balloon pump (IABP) in 337 patients
not in cardiogenic shock.8 The primary endpoint was infarct
size. There was no difference between the two groups; in fact,
there was a trend toward a larger infarct in the group with the
IABP.8
The DTU STEMI pilot trial included 50 patients unloaded
with an Impella CP and tested the hypothesis that delaying
reperfusion by 30 minutes after starting unloading with an
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Impella CP was feasible.9 The trial results showed that this
strategy was feasible and did not increase infarct size.
However, there appeared to be no difference in the outcomes.9
The DTU STEMI trial is ongoing, testing whether unloading
with an Impella and delaying reperfusion compared to
conventional therapy will help.
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Conclusion
In conclusion, if applied early in animal studies,
percutaneous MCS to reduce reperfusion injury can
effectively reduce infarct size. Effective unloading appears
essential so that left ventricular assist devices, such as the
Impella, are more efficient than ECMO and possibly balloon
pumps. The optimal timing of reperfusion is uncertain and is
being further investigated in clinical trials. There is still little
information on the development of acute heart failure and
cardiogenic shock. However, MCS serves other purposes for
cardiogenic shock patients, such as supplying blood flow to
the brain and kidneys.
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